2023-04-012024-03-312024-03-31false07176765Meducate Healthcare Ltd2025-01-31falseiso4217:GBPxbrli:pure071767652023-04-01071767652024-03-31071767652023-04-012024-03-31071767652022-04-01071767652023-03-31071767652022-04-012023-03-3107176765bus:SmallEntities2023-04-012024-03-3107176765bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3107176765bus:FullAccounts2023-04-012024-03-3107176765bus:PrivateLimitedCompanyLtd2023-04-012024-03-3107176765core:WithinOneYear2024-03-3107176765core:AfterOneYear2024-03-3107176765core:WithinOneYear2023-03-3107176765core:AfterOneYear2023-03-3107176765core:ShareCapital2024-03-3107176765core:SharePremium2024-03-3107176765core:RevaluationReserve2024-03-3107176765core:OtherReservesSubtotal2024-03-3107176765core:RetainedEarningsAccumulatedLosses2024-03-3107176765core:ShareCapital2023-03-3107176765core:SharePremium2023-03-3107176765core:RevaluationReserve2023-03-3107176765core:OtherReservesSubtotal2023-03-3107176765core:RetainedEarningsAccumulatedLosses2023-03-3107176765core:LandBuildings2024-03-3107176765core:PlantMachinery2024-03-3107176765core:Vehicles2024-03-3107176765core:FurnitureFittings2024-03-3107176765core:OfficeEquipment2024-03-3107176765core:NetGoodwill2024-03-3107176765core:IntangibleAssetsOtherThanGoodwill2024-03-3107176765core:ListedExchangeTraded2024-03-3107176765core:UnlistedNon-exchangeTraded2024-03-3107176765core:LandBuildings2023-03-3107176765core:PlantMachinery2023-03-3107176765core:Vehicles2023-03-3107176765core:FurnitureFittings2023-03-3107176765core:OfficeEquipment2023-03-3107176765core:NetGoodwill2023-03-3107176765core:IntangibleAssetsOtherThanGoodwill2023-03-3107176765core:ListedExchangeTraded2023-03-3107176765core:UnlistedNon-exchangeTraded2023-03-3107176765core:LandBuildings2023-04-012024-03-3107176765core:PlantMachinery2023-04-012024-03-3107176765core:Vehicles2023-04-012024-03-3107176765core:FurnitureFittings2023-04-012024-03-3107176765core:OfficeEquipment2023-04-012024-03-3107176765core:NetGoodwill2023-04-012024-03-3107176765core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107176765core:ListedExchangeTraded2023-04-012024-03-3107176765core:UnlistedNon-exchangeTraded2023-04-012024-03-3107176765core:MoreThanFiveYears2023-04-012024-03-3107176765core:Non-currentFinancialInstruments2024-03-3107176765core:Non-currentFinancialInstruments2023-03-3107176765dpl:CostSales2023-04-012024-03-3107176765dpl:DistributionCosts2023-04-012024-03-3107176765core:LandBuildings2023-04-012024-03-3107176765core:PlantMachinery2023-04-012024-03-3107176765core:Vehicles2023-04-012024-03-3107176765core:FurnitureFittings2023-04-012024-03-3107176765core:OfficeEquipment2023-04-012024-03-3107176765dpl:AdministrativeExpenses2023-04-012024-03-3107176765core:NetGoodwill2023-04-012024-03-3107176765core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107176765dpl:GroupUndertakings2023-04-012024-03-3107176765dpl:ParticipatingInterests2023-04-012024-03-3107176765dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107176765core:ListedExchangeTraded2023-04-012024-03-3107176765dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107176765core:UnlistedNon-exchangeTraded2023-04-012024-03-3107176765dpl:CostSales2022-04-012023-03-3107176765dpl:DistributionCosts2022-04-012023-03-3107176765core:LandBuildings2022-04-012023-03-3107176765core:PlantMachinery2022-04-012023-03-3107176765core:Vehicles2022-04-012023-03-3107176765core:FurnitureFittings2022-04-012023-03-3107176765core:OfficeEquipment2022-04-012023-03-3107176765dpl:AdministrativeExpenses2022-04-012023-03-3107176765core:NetGoodwill2022-04-012023-03-3107176765core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107176765dpl:GroupUndertakings2022-04-012023-03-3107176765dpl:ParticipatingInterests2022-04-012023-03-3107176765dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107176765core:ListedExchangeTraded2022-04-012023-03-3107176765dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107176765core:UnlistedNon-exchangeTraded2022-04-012023-03-3107176765core:NetGoodwill2024-03-3107176765core:IntangibleAssetsOtherThanGoodwill2024-03-3107176765core:LandBuildings2024-03-3107176765core:PlantMachinery2024-03-3107176765core:Vehicles2024-03-3107176765core:FurnitureFittings2024-03-3107176765core:OfficeEquipment2024-03-3107176765core:AfterOneYear2024-03-3107176765core:WithinOneYear2024-03-3107176765core:ListedExchangeTraded2024-03-3107176765core:UnlistedNon-exchangeTraded2024-03-3107176765core:ShareCapital2024-03-3107176765core:SharePremium2024-03-3107176765core:RevaluationReserve2024-03-3107176765core:OtherReservesSubtotal2024-03-3107176765core:RetainedEarningsAccumulatedLosses2024-03-3107176765core:NetGoodwill2023-03-3107176765core:IntangibleAssetsOtherThanGoodwill2023-03-3107176765core:LandBuildings2023-03-3107176765core:PlantMachinery2023-03-3107176765core:Vehicles2023-03-3107176765core:FurnitureFittings2023-03-3107176765core:OfficeEquipment2023-03-3107176765core:AfterOneYear2023-03-3107176765core:WithinOneYear2023-03-3107176765core:ListedExchangeTraded2023-03-3107176765core:UnlistedNon-exchangeTraded2023-03-3107176765core:ShareCapital2023-03-3107176765core:SharePremium2023-03-3107176765core:RevaluationReserve2023-03-3107176765core:OtherReservesSubtotal2023-03-3107176765core:RetainedEarningsAccumulatedLosses2023-03-3107176765core:NetGoodwill2022-04-0107176765core:IntangibleAssetsOtherThanGoodwill2022-04-0107176765core:LandBuildings2022-04-0107176765core:PlantMachinery2022-04-0107176765core:Vehicles2022-04-0107176765core:FurnitureFittings2022-04-0107176765core:OfficeEquipment2022-04-0107176765core:AfterOneYear2022-04-0107176765core:WithinOneYear2022-04-0107176765core:ListedExchangeTraded2022-04-0107176765core:UnlistedNon-exchangeTraded2022-04-0107176765core:ShareCapital2022-04-0107176765core:SharePremium2022-04-0107176765core:RevaluationReserve2022-04-0107176765core:OtherReservesSubtotal2022-04-0107176765core:RetainedEarningsAccumulatedLosses2022-04-0107176765core:AfterOneYear2023-04-012024-03-3107176765core:WithinOneYear2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3107176765core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107176765core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107176765core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107176765core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107176765core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107176765bus:Director12023-04-012024-03-31

Meducate Healthcare Ltd

Registered Number
07176765
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

Meducate Healthcare Ltd
Company Information
for the year from 1 April 2023 to 31 March 2024

Director

Fiona Flaherty

Registered Address

24 Pentire Road
London
E17 4BZ

Registered Number

07176765 (England and Wales)
Meducate Healthcare Ltd
Balance Sheet as at
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets32,157-
2,157-
Current assets
Debtors-4,488
Cash at bank and on hand36,2773,673
36,2778,161
Creditors amounts falling due within one year4(19,080)(8,048)
Net current assets (liabilities)17,197113
Total assets less current liabilities19,354113
Provisions for liabilities5(539)-
Net assets18,815113
Capital and reserves
Called up share capital100100
Profit and loss account18,71513
Shareholders' funds18,815113
The financial statements were approved and authorised for issue by the Director on 31 January 2025, and are signed on its behalf by:
Fiona Flaherty
Director
Registered Company No. 07176765
Meducate Healthcare Ltd
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions3,2353,235
At 31 March 243,2353,235
Depreciation and impairment
Charge for year1,0781,078
At 31 March 241,0781,078
Net book value
At 31 March 242,1572,157
At 31 March 23--
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables2,2202,220
Amounts owed to related parties73-
Taxation and social security13,8473,608
Accrued liabilities and deferred income2,9402,220
Total19,0808,048
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)539-
Total539-